Sponsor Check › Person
Related person on Form D filings · address states as listed: CA, NY, MN, CT, FL, NC · listed Jul 15, 2009 → May 31, 2022
Data last updated: Oct 23, 2026, 5:45 PM ET · Courts (RECAP) last checked: Oct 23, 2026, 11:57 PM ET · SEC enforcement last checked: not yet
Privacy: business-related public information only. Residential addresses are never shown; only the state from the filing.
The five facts investors ask about first. Each section states what was searched and when. Items still in human review are not shown.
None found in sources searched.
Sources searched: CourtListener bulk data (RECAP dockets as of 2026-09-30) — federal district + bankruptcy courts; live RECAP re-check pending. State courts: not yet searched. PACER: not searched. · Last checked Oct 23, 2026, 11:57 PM ET.
State courts: not yet searched. No state offers a lawful automated statewide source PartnerFacts can use today. Texas (re:SearchTX) terms prohibit storing results in a database open to third parties; New York (WebCivil) and Massachusetts (MassCourts) require a browser check that blocks scripted queries; California has no statewide index (58 county portals; Rule of Court 2.503 grants name-based access case by case); Florida, Utah and Illinois offer paid or partial access whose terms for automated use are unverified. Washington (dw.courts.wa.gov; bulk index reports under a JISC data-dissemination agreement), Delaware (CourtConnect; Court of Chancery not included) and Arizona (apps.azcourts.gov/publicaccess, which has an official channel to request high-volume access) are the candidates; PartnerFacts will request written permission before any automated search. Federal courts are searched through CourtListener / RECAP.
SEC enforcement searched: SEC litigation releases and administrative proceedings — respondent names in the sec.gov index titles (30,205 releases, 1995-09-19 to 2026-10-23); release text is read only to confirm a candidate. Names that appear only in the body of a release are not found. — not yet searched; State securities regulators searched: AZ (Corporation Commission Securities Division), CA (DFPI — 16 of 12,159 DFPI respondent pages read so far; sponsor-name matches are read first), DE (DOJ Investor Protection Unit), TX (State Securities Board), WA (DFI) — last crawled Oct 23, 2026, 9:57 PM ET. Other states: not yet searched.
Not yet searched.
Search queued. Results are added automatically; check back later or follow this page to be notified.
None found in sources searched.
Sources searched: Federal bankruptcy courts via CourtListener / RECAP archive (federal district courts, federal bankruptcy courts). State courts: not yet searched. PACER: not searched (RECAP only). · Last checked Oct 23, 2026, 11:57 PM ET.
State courts: not yet searched. No state offers a lawful automated statewide source PartnerFacts can use today. Texas (re:SearchTX) terms prohibit storing results in a database open to third parties; New York (WebCivil) and Massachusetts (MassCourts) require a browser check that blocks scripted queries; California has no statewide index (58 county portals; Rule of Court 2.503 grants name-based access case by case); Florida, Utah and Illinois offer paid or partial access whose terms for automated use are unverified. Washington (dw.courts.wa.gov; bulk index reports under a JISC data-dissemination agreement), Delaware (CourtConnect; Court of Chancery not included) and Arizona (apps.azcourts.gov/publicaccess, which has an official channel to request high-volume access) are the candidates; PartnerFacts will request written permission before any automated search. Federal courts are searched through CourtListener / RECAP.
Comparisons are made for sponsors and sponsor groups, not individual people.
32 of 57 offerings report sales commissions totalling $7,376,329; 0 report finder's fees; 5 report proceeds to related persons totalling $993,500. (includes amounts the issuer reported as estimates)
| Source | Offering (latest filing) | Sales commissions | Finder's fees | To insiders | Paid to sell it |
|---|---|---|---|---|---|
| EDGAR ↗ | Jun 22, 2026 D/A File 021-568890 | $229,440 (est.) | $0 | $0 Other than the payment of salaries and other compensation and benefits, no officer, director or promoter will receive any payments from the proceeds of this offering. | Laidlaw & Company (UK) Ltd. BrokerCheck CRD 119037 ↗ |
| EDGAR ↗ | Feb 26, 2025 D File 021-539301 | $475,558 (est.) | $0 | $0 Other than the payment of salaries and other compensation and benefits, no officer, director or promoter will receive any payments from the proceeds of this offering. | Laidlaw & Company (UK) Ltd. BrokerCheck CRD 119037 ↗ |
| EDGAR ↗ | Apr 12, 2024 D File 021-510464 | $420,000 | $0 | $210,000 The Company will use $210,000 to repay a non-interest bearing loan issued by an affiliate of the Company. | Laidlaw & Company (UK) Ltd. BrokerCheck CRD 000119037 ↗ |
| EDGAR ↗ | Jan 16, 2024 D File 021-502547 | $0 | $0 | $0 | None listed on this filing |
| EDGAR ↗ | Dec 14, 2023 D File 021-499738 | $15,000 (est.) | $0 | $60,000 The Company will use a portion of net pf proceeds to repay a promissory note in the principal amount of $60,000 issued to Matthew Eitner, the Chief Executive Officer of the placement agent and member of the Board of Directors of the Company. | Laidlaw & Company (UK) Ltd. BrokerCheck CRD 119037 ↗ |
| EDGAR ↗ | Nov 9, 2023 D/A File 021-464374 | $385,282 (est.) | $0 | $0 | Laidlaw & Company (UK) Ltd. BrokerCheck CRD 119037 ↗ |
| EDGAR ↗ | Oct 25, 2023 D File 021-495636 | $59,750 | $0 | $0 | Laidlaw & Company (UK) Ltd. BrokerCheck CRD 119037 ↗ |
| EDGAR ↗ | Oct 6, 2023 D File 021-494088 | $30,000 | $0 | $0 | Laidlaw & Company (UK) Ltd. BrokerCheck CRD 119037 ↗ |
| EDGAR ↗ | Sep 27, 2023 D File 021-493222 | $53,000 | $0 | $0 | Laidlaw & Company (UK) Ltd. BrokerCheck CRD 119037 ↗ |
| EDGAR ↗ | Aug 17, 2023 D/A File 021-452571 | $600,000 | $0 | $0 (est.) | Laidlaw & Company (UK) Ltd. BrokerCheck CRD 119037 ↗ |
| EDGAR ↗ | Aug 1, 2023 D File 021-488485 | $150,000 | $0 | $0 | Laidlaw & Company (UK) Ltd. BrokerCheck CRD 119037 ↗ |
| EDGAR ↗ | May 26, 2023 D File 021-482765 | $104,617 | $0 | $0 | Laidlaw & Company (UK) Ltd. BrokerCheck CRD 119037 ↗ |
| EDGAR ↗ | Apr 28, 2023 D File 021-480375 | $11,250 | $0 | $0 | Laidlaw & Company (UK) Ltd. BrokerCheck CRD 119037 ↗ |
| EDGAR ↗ | Apr 7, 2023 D File 021-478197 | $0 | $0 | $0 (est.) | None listed on this filing |
| EDGAR ↗ | Apr 5, 2023 D File 021-478039 | $64,610 | $0 | $0 | Laidlaw & Company (UK) Ltd. BrokerCheck CRD 119037 ↗ |
| EDGAR ↗ | Mar 20, 2023 D File 021-476378 | $150,000 | $0 | $0 | Laidlaw & Company (UK) Ltd. BrokerCheck CRD 119037 ↗ |
| EDGAR ↗ | Feb 14, 2023 D File 021-473465 | $0 | $0 | $0 | None listed on this filing |
| EDGAR ↗ | Feb 13, 2023 D/A File 021-470919 | $43,760 | $0 | $0 | Laidlaw & Company (UK) Ltd. BrokerCheck CRD 119037 ↗ |
| EDGAR ↗ | Feb 13, 2023 D File 021-473342 | $80,000 | $0 | $0 | Laidlaw & Company (UK) Ltd. BrokerCheck CRD 119037 ↗ |
| EDGAR ↗ | Jan 31, 2023 D File 021-472303 | $104,000 | $0 | $0 | Laidlaw & Company (UK) Ltd. BrokerCheck CRD 119037 ↗ |
| EDGAR ↗ | Jan 31, 2023 D File 021-472305 | $0 | $0 | $0 | None listed on this filing |
| EDGAR ↗ | Jan 4, 2023 D File 021-469694 | $40,000 | $0 | $0 | Laidlaw & Company (UK) Ltd. BrokerCheck CRD 119037 ↗ |
| EDGAR ↗ | Dec 30, 2022 D/A File 021-466070 | $40,000 | $0 | $0 | Laidlaw & Company (UK) Ltd. BrokerCheck CRD 119037 ↗ |
| EDGAR ↗ | Jul 28, 2022 D/A File 021-454012 | $42,980 (est.) | $0 | $60,000 The Company will use a portion of net pf proceeds to repay a promissory note in the principal amount of $60,000 issued to Matthew Eitner, the Chief Executive Officer of the placement agent and member of the Board of Directors of the Company. | Laidlaw & Company (UK) Ltd. BrokerCheck CRD 119037 ↗ |
| EDGAR ↗ | Jun 16, 2022 D File 021-449491 | $36,000 (est.) | $0 | $0 | Laidlaw & Company (UK) Ltd. BrokerCheck CRD 119037 ↗ |
| EDGAR ↗ | May 31, 2022 D File 021-447583 | $0 | $0 | $0 | None listed on this filing |
| EDGAR ↗ | Dec 28, 2021 D File 021-426873 | $560,000 (est.) | $0 | $0 (est.) Some of the proceeds of the offering may be used for general working capital purposes which may include the payment of salaries and other fees to those individuals listed in Item 3. To date, no offering proceeds have been used for such purposes. | Laidlaw & Company (UK) Ltd. BrokerCheck CRD 119037 ↗ |
| EDGAR ↗ | Sep 1, 2021 D File 021-411975 | $250,201 (est.) | $0 | $0 | Laidlaw & Company (UK) Ltd. BrokerCheck CRD 119037 ↗ |
| EDGAR ↗ | Jul 13, 2021 D File 021-406044 | $402,000 (est.) | $0 | $283,500 (est.) | Laidlaw & Company (UK) Ltd. BrokerCheck CRD 119037 ↗ |
| EDGAR ↗ | Jul 9, 2021 D File 021-405765 | $0 | $0 | $0 | None listed on this filing |
| EDGAR ↗ | Mar 31, 2021 D/A File 021-356232 | $0 | $0 | $0 | None listed on this filing |
| EDGAR ↗ | Mar 26, 2021 D File 021-393628 | $1,200,000 (est.) | $0 | $0 (est.) Some of the proceeds may be used for general working capital purposes which may include the payment of salaries and other fees to those listed in Item 3. | Laidlaw & Company (UK) Ltd. BrokerCheck CRD 119037 ↗ |
| EDGAR ↗ | May 5, 2020 D File 021-366271 | $0 | $0 | $0 | None listed on this filing |
| EDGAR ↗ | Nov 5, 2019 D File 021-352622 | $0 | $0 | $0 | None listed on this filing |
| EDGAR ↗ | Oct 23, 2019 D File 021-351657 | $770,000 (est.) | $0 | $0 (est.) Some of the proceeds may be used for general working capital purposes which may include the payment of salaries and other fees to those listed in Item 3. | Laidlaw & Company (UK) Ltd. BrokerCheck CRD 119037 ↗ |
| EDGAR ↗ | Sep 9, 2019 D File 021-348265 | $0 | $0 | $0 | None listed on this filing |
| EDGAR ↗ | Aug 20, 2019 D File 021-347028 | $0 | $0 | $0 | None listed on this filing |
| EDGAR ↗ | Mar 28, 2019 D File 021-335957 | $0 | $0 | $0 | None listed on this filing |
| EDGAR ↗ | Aug 28, 2018 D File 021-320228 | $150,035 | $0 | $0 | Laidlaw & Company (UK) Ltd. BrokerCheck CRD 119037 ↗ |
| EDGAR ↗ | Feb 27, 2018 D File 021-306571 | $0 | $0 | $0 | None listed on this filing |
| EDGAR ↗ | Nov 17, 2017 D File 021-299042 | $0 | $0 | $0 | None listed on this filing |
| EDGAR ↗ | Jul 20, 2017 D File 021-291219 | $0 | $0 | $0 | None listed on this filing |
| EDGAR ↗ | Mar 30, 2017 D File 021-283700 | $0 | $0 | $0 | None listed on this filing |
| EDGAR ↗ | Oct 31, 2016 D File 021-273528 | $31,191 | $0 | $0 | Laidlaw & Company (UK) Ltd. BrokerCheck CRD 119037 ↗ |
| EDGAR ↗ | Apr 20, 2016 D File 021-261677 | $0 | $0 | $0 | None listed on this filing |
| EDGAR ↗ | Nov 23, 2015 D File 021-251698 | $59,400 | $0 | $0 | Laidlaw & Company (UK) Ltd. BrokerCheck CRD 119037 ↗ |
| EDGAR ↗ | May 19, 2015 D File 021-240187 | $0 | $0 | $0 | None listed on this filing |
| EDGAR ↗ | Apr 3, 2015 D/A File 021-231214 | $481,080 | $0 | $0 | Laidlaw & Company (UK) Ltd. BrokerCheck CRD 119037 ↗ |
| EDGAR ↗ | Sep 25, 2014 D/A File 021-223449 | $46,800 | $0 | $0 | Laidlaw & Company (UK) Ltd. BrokerCheck CRD 119037 ↗ |
| EDGAR ↗ | Jan 30, 2014 D File 021-210996 | $0 | $0 | $0 | None listed on this filing |
| EDGAR ↗ | Feb 8, 2012 D/A File 021-160078 | $290,375 (est.) | $0 | $380,000 (est.) | Salomon Whitney LLC BrokerCheck CRD 145012 ↗ via Salomon Whitney LLC (CRD 145012 ↗) |
| EDGAR ↗ | Sep 14, 2011 D File 021-165873 | $0 | $0 | $0 | None listed on this filing |
| EDGAR ↗ | Jul 21, 2011 D File 021-163252 | $0 | $0 | $0 | None listed on this filing |
| EDGAR ↗ | Jul 21, 2011 D File 021-163253 | $0 | $0 | $0 | None listed on this filing |
| EDGAR ↗ | Jul 21, 2011 D File 021-163254 | $0 | $0 | $0 | None listed on this filing |
| EDGAR ↗ | Sep 24, 2010 D File 021-148130 | $0 | $0 | $0 | None listed on this filing |
| EDGAR ↗ | Jul 15, 2009 D File 021-111611 | $0 | $0 | $0 (est.) | None listed on this filing |
As reported by the issuer on Form D (Items 12–15), latest filing per offering (one offering = one SEC file number; an amendment updates its offering rather than adding one). "To insiders" = gross proceeds used for payments to executive officers, directors or promoters. "—" = not reported on that filing. Amounts marked (est.) were reported as estimates. "Paid to sell it" = sales compensation recipients named on that filing (Item 12), each linked to FINRA BrokerCheck when a CRD number is reported.
Counted across every filing this person is listed on (latest filing per offering, per issuer).
| Source | Issuer | Role | Filed | Form | Offering | Sold | Investors | Min. investment |
|---|---|---|---|---|---|---|---|---|
| EDGAR ↗ | ADAPTIN BIO, INC. | Director | Jun 22, 2026 | D/A | $4,000,000 similar: $2,000,000–$19,999,994 | $1,912,000 | 19 similar: 2–16 | No minimum reported similar: $10,000–$50,000 |
| EDGAR ↗ | ADAPTIN BIO, INC. | Director | Mar 23, 2026 | D/A | $4,000,000 similar: $2,000,000–$19,999,994 | $1,652,000 | 13 similar: 2–16 | No minimum reported similar: $10,000–$50,000 |
| EDGAR ↗ | ADAPTIN BIO, INC. | Director | Feb 20, 2026 | D/A | $4,000,000 similar: $2,000,000–$19,999,994 | $1,297,000 | 10 similar: 2–16 | No minimum reported similar: $10,000–$50,000 |
| EDGAR ↗ | ADAPTIN BIO, INC. | Director | Jan 5, 2026 | D | $4,000,000 similar: $2,000,000–$19,999,994 | $1,000,000 | 7 similar: 2–16 | No minimum reported similar: $10,000–$50,000 |
| EDGAR ↗ | ADAPTIN BIO, INC. | Director | Feb 26, 2025 | D | $23,375,010 similar: $2,000,000–$19,999,994 | $13,077,849 | 95 similar: 2–16 | No minimum reported similar: $10,000–$50,000 |
| EDGAR ↗ | Algorithm Sciences, Inc. | Director | Apr 12, 2024 | D | $23,500,000 similar: $2,000,000–$19,999,994 | $350,000 | 2 similar: 2–16 | No minimum reported similar: $10,000–$50,000 |
| EDGAR ↗ | BioSig Technologies, Inc. | Director | Jan 16, 2024 | D | $1,478,526 similar: $829,831–$9,999,998 | $1,478,526 | 7 similar: 2–15 | No minimum reported similar: $10,000–$54,310 |
| EDGAR ↗ | PD Theranostics, Inc. | Executive Officer, Director Chief Executive Officer | Dec 14, 2023 | D | $1,000,000 similar: $2,000,000–$19,999,994 | $150,000 | 2 similar: 2–16 | No minimum reported similar: $10,000–$50,000 |
| EDGAR ↗ | Voltron Therapeutics, Inc. | Executive Officer, Director Chief Executive Officer | Nov 9, 2023 | D/A | Indefinite similar: $2,000,000–$19,999,994 | $3,210,680 | 63 similar: 2–16 | No minimum reported similar: $10,000–$50,000 |
| EDGAR ↗ | BioSig Technologies, Inc. | Director | Oct 25, 2023 | D | $860,933 similar: $829,831–$9,999,998 | $860,933 | 20 similar: 2–15 | No minimum reported similar: $10,000–$54,310 |
| EDGAR ↗ | BioSig Technologies, Inc. | Director | Oct 6, 2023 | D | $1,169,715 similar: $829,831–$9,999,998 | $1,169,715 | 10 similar: 2–15 | No minimum reported similar: $10,000–$54,310 |
| EDGAR ↗ | BioSig Technologies, Inc. | Director | Sep 27, 2023 | D | $794,032 similar: $829,831–$9,999,998 | $794,032 | 4 similar: 2–15 | No minimum reported similar: $10,000–$54,310 |
| EDGAR ↗ | Aerwave Medical, Inc. | Director | Aug 17, 2023 | D/A | $5,000,000 similar: $829,831–$9,999,998 | $3,965,195 | 58 similar: 2–15 | No minimum reported similar: $10,000–$54,310 |
| EDGAR ↗ | BioSig Technologies, Inc. | Director | Aug 1, 2023 | D | $2,204,136 similar: $829,831–$9,999,998 | $2,204,136 | 1 similar: 2–15 | No minimum reported similar: $10,000–$54,310 |
| EDGAR ↗ | BioSig Technologies, Inc. | Director | May 26, 2023 | D | $3,694,920 similar: $829,831–$9,999,998 | $3,694,920 | 20 similar: 2–15 | No minimum reported similar: $10,000–$54,310 |
| EDGAR ↗ | BioSig Technologies, Inc. | Director | Apr 28, 2023 | D | $1,392,738 similar: $829,831–$9,999,998 | $1,392,738 | 14 similar: 2–15 | No minimum reported similar: $10,000–$54,310 |
| EDGAR ↗ | Algorithm Sciences, Inc. | Director | Apr 7, 2023 | D | $5,000,000 similar: $2,000,000–$19,999,994 | $684,651 | 35 similar: 2–16 | $50,000 similar: $10,000–$50,000 |
| EDGAR ↗ | BioSig Technologies, Inc. | Director | Apr 5, 2023 | D | $1,497,611 similar: $829,831–$9,999,998 | $1,497,611 | 5 similar: 2–15 | No minimum reported similar: $10,000–$54,310 |
| EDGAR ↗ | BioSig Technologies, Inc. | Director | Mar 20, 2023 | D | $2,531,520 similar: $829,831–$9,999,998 | $2,531,520 | 17 similar: 2–15 | No minimum reported similar: $10,000–$54,310 |
| EDGAR ↗ | BioSig Technologies, Inc. | Director | Feb 14, 2023 | D | $603,045 similar: $829,831–$9,999,998 | $603,045 | 5 similar: 2–15 | No minimum reported similar: $10,000–$54,310 |
| EDGAR ↗ | BioSig Technologies, Inc. | Director | Feb 13, 2023 | D | $2,000,750 similar: $829,831–$9,999,998 | $2,000,750 | 7 similar: 2–15 | No minimum reported similar: $10,000–$54,310 |
| EDGAR ↗ | BioSig Technologies, Inc. | Director | Feb 13, 2023 | D/A | $1,814,254 similar: $829,831–$9,999,998 | $1,814,254 | 17 similar: 2–15 | No minimum reported similar: $10,000–$54,310 |
| EDGAR ↗ | BioSig Technologies, Inc. | Director | Jan 31, 2023 | D | $233,846 similar: $829,831–$9,999,998 | $233,846 | 3 similar: 2–15 | No minimum reported similar: $10,000–$54,310 |
| EDGAR ↗ | BioSig Technologies, Inc. | Director | Jan 31, 2023 | D | $1,897,955 similar: $829,831–$9,999,998 | $1,897,955 | 1 similar: 2–15 | No minimum reported similar: $10,000–$54,310 |
| EDGAR ↗ | BioSig Technologies, Inc. | Director | Jan 17, 2023 | D | $1,814,254 similar: $829,831–$9,999,998 | $1,814,254 | 17 similar: 2–15 | No minimum reported similar: $10,000–$54,310 |
| EDGAR ↗ | BioSig Technologies, Inc. | Director | Jan 4, 2023 | D | $1,098,092 similar: $829,831–$9,999,998 | $1,098,092 | 8 similar: 2–15 | No minimum reported similar: $10,000–$54,310 |
| EDGAR ↗ | BioSig Technologies, Inc. | Director | Dec 30, 2022 | D/A | $1,452,000 similar: $829,831–$9,999,998 | $1,452,000 | 10 similar: 2–15 | No minimum reported similar: $10,000–$54,310 |
| EDGAR ↗ | BioSig Technologies, Inc. | Director | Nov 29, 2022 | D | $1,452,000 similar: $829,831–$9,999,998 | $1,452,000 | 10 similar: 2–15 | No minimum reported similar: $10,000–$54,310 |
| EDGAR ↗ | Voltron Therapeutics, Inc. | Executive Officer, Director Chief Executive Officer | Nov 9, 2022 | D | Indefinite similar: $2,000,000–$19,999,994 | $515,000 | 8 similar: 2–16 | No minimum reported similar: $10,000–$50,000 |
| EDGAR ↗ | PD Theranostics, Inc. | Executive Officer, Director Chief Executive Officer | Jul 28, 2022 | D/A | $5,940,000 similar: $2,000,000–$19,999,994 | $358,165 | 3 similar: 2–16 | No minimum reported similar: $10,000–$50,000 |
| EDGAR ↗ | PD Theranostics, Inc. | Executive Officer, Director Chief Executive Officer | Jul 28, 2022 | D | $5,940,000 similar: $2,000,000–$19,999,994 | $358,165 | 3 similar: 2–16 | No minimum reported similar: $10,000–$50,000 |
| EDGAR ↗ | Aerwave Medical, Inc. | Director | Jul 15, 2022 | D | $5,000,000 similar: $829,831–$9,999,998 | $490,000 | 8 similar: 2–15 | No minimum reported similar: $10,000–$54,310 |
| EDGAR ↗ | Voltron Therapeutics, Inc. | Executive Officer, Director Chief Executive Officer | Jun 16, 2022 | D | $5,000,000 similar: $2,000,000–$19,999,994 | $300,000 | 1 similar: 2–16 | No minimum reported similar: $10,000–$50,000 |
| EDGAR ↗ | Tuesday Capital V, L.P. | Executive Officer Managing Member of the General Partner | May 31, 2022 | D | $30,000,000 similar: $155,000–$5,250,000 | $0 | 0 similar: 4–27 | No minimum reported similar: $1,000–$100,000 |
| EDGAR ↗ | Algorithm Sciences, Inc. | Director | Dec 28, 2021 | D | $7,000,000 similar: $2,000,000–$19,999,994 | $1,135,000 | 10 similar: 2–16 | $25,000 similar: $10,000–$50,000 |
| EDGAR ↗ | Voltron Therapeutics, Inc. | Executive Officer, Director Chief Executive Officer | Sep 1, 2021 | D | $12,000,000 similar: $2,000,000–$19,999,994 | $2,502,011 | 36 similar: 2–16 | No minimum reported similar: $10,000–$50,000 |
| EDGAR ↗ | Voltron Therapeutics, Inc. | Executive Officer, Director Chief Executive Officer | Jul 13, 2021 | D | $3,349,428 similar: $1,694,259–$16,000,000 | $3,349,428 | 49 similar: 1–13 | No minimum reported similar: $10,000–$55,000 |
| EDGAR ↗ | BioSig Technologies, Inc. | Director | Jul 9, 2021 | D | $600,000 similar: $829,831–$9,999,998 | $600,000 | 1 similar: 2–15 | No minimum reported similar: $10,000–$54,310 |
| EDGAR ↗ | Tuesday Capital IV, L.P. | Executive Officer Managing Member of the General Partner | Mar 31, 2021 | D/A | $30,092,787 similar: $155,000–$5,250,000 | $30,092,787 | 34 similar: 4–27 | No minimum reported similar: $1,000–$100,000 |
| EDGAR ↗ | Algorithm Sciences, Inc. | Director | Mar 26, 2021 | D | $10,000,000 similar: $1,100,015–$10,001,163 | $2,899,500 | 39 similar: 2–14 | No minimum reported similar: $5,000–$50,000 |
| EDGAR ↗ | BioSig Technologies, Inc. | Director | May 5, 2020 | D | $600,000 similar: $829,831–$9,999,998 | $600,000 | 1 similar: 2–15 | No minimum reported similar: $10,000–$54,310 |
| EDGAR ↗ | Tuesday Capital IV, L.P. | Executive Officer Managing Member of the General Partner | Dec 23, 2019 | D | $40,000,000 similar: $155,000–$5,250,000 | $0 | 0 similar: 4–27 | No minimum reported similar: $1,000–$100,000 |
| EDGAR ↗ | BioSig Technologies, Inc. | Director | Nov 5, 2019 | D | $20,000,000 similar: $829,831–$9,999,998 | $686,370 | 8 similar: 2–15 | No minimum reported similar: $10,000–$54,310 |
| EDGAR ↗ | Algorithm Sciences, Inc. | Director | Oct 23, 2019 | D | $6,000,000 similar: $1,100,015–$10,001,163 | $2,087,980 | 23 similar: 2–14 | No minimum reported similar: $5,000–$50,000 |
| EDGAR ↗ | BioSig Technologies, Inc. | Director | Sep 9, 2019 | D | $160,000 similar: $829,831–$9,999,998 | $160,000 | 1 similar: 2–15 | No minimum reported similar: $10,000–$54,310 |
| EDGAR ↗ | BioSig Technologies, Inc. | Director | Aug 20, 2019 | D | $3,600,000 similar: $829,831–$9,999,998 | $3,260,000 | 17 similar: 2–15 | No minimum reported similar: $10,000–$54,310 |
| EDGAR ↗ | BioSig Technologies, Inc. | Director | Mar 28, 2019 | D | $8,620,506 similar: $829,831–$9,999,998 | $8,620,506 | 103 similar: 2–15 | No minimum reported similar: $10,000–$54,310 |
| EDGAR ↗ | BioSig Technologies, Inc. | Director | Aug 28, 2018 | D | $10,000,000 similar: $829,831–$9,999,998 | $4,071,189 | 72 similar: 2–15 | No minimum reported similar: $10,000–$54,310 |
| EDGAR ↗ | BioSig Technologies, Inc. | Director | Feb 27, 2018 | D | $1,500,000 similar: $829,831–$9,999,998 | $1,500,000 | 2 similar: 2–15 | No minimum reported similar: $10,000–$54,310 |
| EDGAR ↗ | BioSig Technologies, Inc. | Director Director | Nov 17, 2017 | D | $2,000,000 similar: $829,831–$9,999,998 | $2,000,000 | 2 similar: 2–15 | No minimum reported similar: $10,000–$54,310 |
| EDGAR ↗ | BioSig Technologies, Inc. | Director Director | Jul 20, 2017 | D | $7,000,000 similar: $2,000,000–$19,999,994 | $1,640,398 | 22 similar: 2–16 | $15,000 similar: $10,000–$50,000 |
| EDGAR ↗ | BioSig Technologies, Inc. | Director | Mar 30, 2017 | D | Indefinite similar: $2,000,000–$19,999,994 | $0 | 1 similar: 2–16 | No minimum reported similar: $10,000–$50,000 |
| EDGAR ↗ | BioSig Technologies, Inc. | Director | Oct 31, 2016 | D | $5,000,001 similar: $2,000,000–$19,999,994 | $519,850 | 4 similar: 2–16 | $15,000 similar: $10,000–$50,000 |
| EDGAR ↗ | Crunch Fund III, L.P. | Executive Officer Managing Member of the General Partner | Apr 20, 2016 | D | $30,000,000 similar: $155,000–$5,250,000 | $0 | 0 similar: 4–27 | No minimum reported similar: $1,000–$100,000 |
| EDGAR ↗ | BioSig Technologies, Inc. | Director | Nov 23, 2015 | D | $7,000,000 similar: $2,000,000–$19,999,994 | $1,020,000 | 14 similar: 2–16 | No minimum reported similar: $10,000–$50,000 |
| EDGAR ↗ | BioSig Technologies, Inc. | Director | May 19, 2015 | D | $450,000 similar: $2,000,000–$19,999,994 | $450,000 | 2 similar: 2–16 | No minimum reported similar: $10,000–$50,000 |
| EDGAR ↗ | BioSig Technologies, Inc. | Director | Apr 3, 2015 | D/A | $10,000,000 similar: $2,000,000–$19,999,994 | $4,009,000 | 107 similar: 2–16 | No minimum reported similar: $10,000–$50,000 |
| EDGAR ↗ | BioSig Technologies, Inc. | Director | Mar 10, 2015 | D/A | $10,000,000 similar: $2,000,000–$19,999,994 | $2,983,100 | 75 similar: 2–16 | No minimum reported similar: $10,000–$50,000 |
| EDGAR ↗ | BioSig Technologies, Inc. | Director | Feb 18, 2015 | D/A | $10,000,000 similar: $2,000,000–$19,999,994 | $2,425,600 | 62 similar: 2–16 | No minimum reported similar: $10,000–$50,000 |
| EDGAR ↗ | BioSig Technologies, Inc. | Director | Jan 30, 2015 | D/A | $10,000,000 similar: $2,000,000–$19,999,994 | $1,583,100 | 40 similar: 2–16 | No minimum reported similar: $10,000–$50,000 |
| EDGAR ↗ | BioSig Technologies, Inc. | Director | Dec 31, 2014 | D | $10,000,000 similar: $2,000,000–$19,999,994 | $512,100 | 24 similar: 2–16 | No minimum reported similar: $10,000–$50,000 |
| EDGAR ↗ | BioSig Technologies, Inc. | Director | Sep 25, 2014 | D/A | $1,000,000 similar: $2,000,000–$19,999,994 | $953,000 | 23 similar: 2–16 | No minimum reported similar: $10,000–$50,000 |
| EDGAR ↗ | BioSig Technologies, Inc. | Director | Aug 22, 2014 | D | $1,000,000 similar: $2,000,000–$19,999,994 | $563,000 | 13 similar: 2–16 | No minimum reported similar: $10,000–$50,000 |
| EDGAR ↗ | Crunch Fund II, L.P. | Executive Officer | Jan 30, 2014 | D | $40,000,000 similar: $155,000–$5,250,000 | $0 | 0 similar: 4–27 | No minimum reported similar: $1,000–$100,000 |
| EDGAR ↗ | Watt Fuel Cell Corp. | Director | Feb 8, 2012 | D/A | $8,006,162 | $2,903,750 | 34 | $52,500 |
| EDGAR ↗ | Watt Fuel Cell Corp. | Director | Dec 21, 2011 | D/A | $8,006,162 | $2,265,000 | 26 | $52,500 |
| EDGAR ↗ | Watt Fuel Cell Corp. | Director | Oct 24, 2011 | D/A | $8,006,162 | $1,766,250 | 19 | $52,500 |
| EDGAR ↗ | Crunch Fund I, L.P. | Executive Officer Patrick Gallagher is a Managing Member of the General Partner of the Issuer. | Sep 14, 2011 | D | Indefinite | $15,700,000 | 25 | $50,000 |
| EDGAR ↗ | Watt Fuel Cell Corp. | Director | Sep 7, 2011 | D/A | $8,006,162 | $1,503,750 | 16 | $52,500 |
| EDGAR ↗ | YouMail, Inc. | Director | Jul 21, 2011 | D | $593,047 | $593,047 | 29 | No minimum reported |
| EDGAR ↗ | YouMail, Inc. | Director | Jul 21, 2011 | D | $1,000,000 | $1,000,000 | 1 | No minimum reported |
| EDGAR ↗ | YouMail, Inc. | Director | Jul 21, 2011 | D | $560,671 | $560,671 | 17 | No minimum reported |
| EDGAR ↗ | Watt Fuel Cell Corp. | Director | Jul 1, 2011 | D/A | $8,006,162 | $550,000 | 5 | $52,500 |
| EDGAR ↗ | Watt Fuel Cell Corp. | Director | May 19, 2011 | D | $8,006,162 | $122,500 | 1 | $52,500 |
| EDGAR ↗ | YouMail, Inc. | Director | Sep 24, 2010 | D | $410,000 | $410,000 | 9 | No minimum reported |
| EDGAR ↗ | YouMail, Inc. | Director | Jul 15, 2009 | D | $2,000,000 | $1,517,415 | 3 | No minimum reported |
Every row is a Form D or D/A on which the issuer listed this name as a related person. Related-person names are matched on first + last name and the address state on the filing; records that share a name but could not be tied together by a second identifier are listed separately below.
"Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years (5 industry/exemption sets on this page); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.
Separate person records under the same name, not combined with this page. Each line says whether it is listed on an issuer this record is also listed on (a second identifier); where it is not, it could be the same person or a different one.
People and management entities the issuers listed as related persons on the same Form D filings as Patrick Gallagher. Source: the EDGAR rows in the table above. Showing the 40 with the most shared filings.
None found in sources searched.
Sources searched: SEC Regulation A Data Sets (Forms 1-A, 1-K, 1-Z; 2015 Q2 → 2026 Q3); SEC Crowdfunding Offerings Data Sets (Form C family; 2016 Q2 → 2026 Q3); EDGAR form index for 2026 Q3 → 2026 Q4 · Last checked Oct 23, 2026, 8:41 PM ET.
Export this report as PDF (members · included free during the launch period)
No corrections have been requested for this page.
Free. Logged with status: received → under review → fixed / confirmed with source.
If this is you or your firm, add a sourced explanation next to any fact. Reviewed before publishing.
Members get an email when Patrick Gallagher appears on a new Form D, or when a court case or SEC action is matched to them. See plans →